Skip to main content
SpringerLink
Log in

Basic therapy for rheumatoid arthritis: Nonsteroidal anti-inflammatory drugs

  • Original Article
  • Published:
Comprehensive Therapy

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are often the initial treatment for rheumatoid arthritis. NSAID-induced inhibition of cyclooxygenase-2 (COX2) and cyclooxygenase-1 appears to correlate with clinical efficacy and toxicity, respectively. Newer NSAIDs with greater COX2 selectivity offer the promise of less toxic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McDuffie FC. Morbidity impact of rheumatoid arthritis on society.Am J Med. 1985;78(suppl 1A):1–5.

    Article  PubMed  CAS  Google Scholar 

  2. Markenson JA. Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis.Semin Arthritis Rheum. 1991;21(suppl 1):4–12.

    Article  PubMed  CAS  Google Scholar 

  3. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.Arthritis Rheum. 1990;33:305–315.

    Article  PubMed  CAS  Google Scholar 

  4. Fremont-Smith K, Bayles TB. Salicylate therapy in rheumatoid arthritis.JAMA. 1965;192:1133–1136.

    PubMed  CAS  Google Scholar 

  5. Heller CA, Ingelfinger JA, Goldman P. Nonsteroidal antiinflammatory drugs and aspirin: Analyzing the scores.Pharmacotherapy. 1985;5:30–38.

    PubMed  CAS  Google Scholar 

  6. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs: differences and similarities.N Engl J Med. 1991;324:1716–1725.

    PubMed  CAS  Google Scholar 

  7. Dewitt DL. Prostaglandin endoperoxide synthase: regulation of enzyme expression.Biochim Biophys Acta. 1991;1083:121–134.

    PubMed  CAS  Google Scholar 

  8. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs.Scand J Rheumatol. 1996;25(suppl 102):9–21.

    Article  Google Scholar 

  9. Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues.J Clin Invest. 1994;93:1095–1101.

    Article  PubMed  CAS  Google Scholar 

  10. Tomlinson A, Appleton I, Moore AR, et al. Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy.Br J Pharmacol. 1994;113:693–98.

    PubMed  CAS  Google Scholar 

  11. Nogawa, S, Zhang R, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.J Neursci. 1997;17:2746–2755.

    CAS  Google Scholar 

  12. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.J Clin Invest. 1994;94:2504–2510.

    Article  PubMed  CAS  Google Scholar 

  13. Dinchuk JE, Car BD, Focht RJ, et al. Renal abnormalities and altered inflammatory response in mice lacking cyclooxygenase II.Nature. 1995;378:406–407.

    Article  PubMed  CAS  Google Scholar 

  14. Slater DM, Bryer LC, Newton R, Moore GE, Bennett PR. Expression of cyclooxygenase type 1 and type 2 in human fetal membranes at term.Am J Obstet Gynecol. 1995;172(1):77–82.

    Article  PubMed  CAS  Google Scholar 

  15. Eberhart CE, Coffey RJ, Radhika A, et al. Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology. 1994;107:1183–1188.

    PubMed  CAS  Google Scholar 

  16. Williams HJ, Ward JR, Marlene JE, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee.Arthritis Rheum. 1993;36:1196–1206.

    Article  PubMed  CAS  Google Scholar 

  17. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers.Am J Gastroenterol. 1998;93:2037–2046.

    Article  PubMed  CAS  Google Scholar 

  18. Polisson R. Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection.Am J Med. 1996;100(suppl 2A)31s-36s.

    Article  PubMed  CAS  Google Scholar 

  19. Clive DM, Stoff SS. Renal syndromes associated with nonsteroidal antiinflammatory drugs.N Engl J Med. 1984;310:563–572.

    PubMed  CAS  Google Scholar 

  20. Spangler RS. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.Semin Arthritis Rheum. 1996;26:435–446.

    Article  PubMed  CAS  Google Scholar 

  21. Vane J. Differential inhibition of cyclooxygenase isoforms: an explanation of the actions of NSAIDs.J Clin Rheumatol. 1998;4(5):s3-s10.

    Article  Google Scholar 

  22. Mitchell JA, Adarasereenont P, Themermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proc Natl Acad Sci USA. 1994;90:11693–11697.

    Article  Google Scholar 

  23. Meade EA, Smith WL, Dewitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.J Biol Chem. 1993;268:3310–3314.

    Google Scholar 

  24. Distal M, Mueller C, Bluhmki E, Fries J. Safety of meloxican: a global analysis of clinical trials.Br J Rheumatol. 1996;35(suppl 1):68–77.

    Google Scholar 

  25. Barner A. Review of clinical trials and benefit/risk ratio of meloxicam.Scand J Rheumatol. 1996;102(suppl):29–37.

    Article  CAS  Google Scholar 

  26. Furst DE. Meloxicam: selective COX-2 inhibition in clinical practice.Semin Arthritis Rheum. 1997;26(suppl 1):21–27.

    Article  PubMed  CAS  Google Scholar 

  27. Freed MI, Audet PA, Zariffa N, et al. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers.J Clin Pharmacol. 1994;34:1098–1108.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah

    Katja F. Daoud MD & H. James Williams MD

  2. Division of Rheumatology, University of Utah School of Medicine Salt Lake City Veterans Affairs Hospital, Salt Lake City, Utah

    Christopher G. Jackson MD

Authors
  1. Katja F. Daoud MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher G. Jackson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. James Williams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Daoud, K.F., Jackson, C.G. & Williams, H.J. Basic therapy for rheumatoid arthritis: Nonsteroidal anti-inflammatory drugs. Compr Ther 25, 427–433 (1999). https://doi.org/10.1007/BF02944294

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02944294

Keywords

Search

Navigation